Patheon to showcase sterile manufacturing back-up supply programme
Key to ensuring consistent and dependable supply of sterile pharmaceutical products
Patheon will feature its sterile pharmaceutical manufacturing back-up supply programme for current and potential customers at the forthcoming Interphex conference in New York. The programme is key to ensuring consistent and dependable supply of sterile pharmaceutical products.
‘With regulatory scrutiny increasing, we recognise how important it is for pharmaceutical companies to have established sterile back-up supply agreements in place,’ said Geoffrey M. Glass, Patheon’s executive vice president of global sales and marketing. ‘Our programme brings a prudent way to manage the risk of supply interruption without building the capacity internally or committing to onerous volume obligations with a contract manufacturing partner.
‘For pharmaceutical companies, the benefit of getting an insurance policy on their sterile supply should largely offset the tech transfer investment.’
Patheon representatives will be available to discuss the company’s back-up sterile supply programme at the forthcoming Interphex Conference in New York, NY 29 – 31 March 2011. The company will be exhibiting at Booth 1233 through the duration of the conference.
For those companies that are interested in discussing this programme and will not be attending the conference, please contact a Patheon representative on +1 866 728 4366.
